Characterizing the GOES-R (GOES-16) Geostationary Lightning Mapper (GLM) On-Orbit Performance

Two overlapping efforts help to characterize the GLM performance, the Post Launch Test (PLT) phase to validate the predicted pre-launch instrument performance and the Post Launch Product Test (PLPT) phase to validate the lightning detection product used in forecast and warning decision-making. This paper documents the calibration and validation plans and activities for the first 6 months of GLM on-orbit testing and validation commencing with first light on 4 January 2017. The PLT phase addresses image quality, on-orbit calibration, RTEP threshold tuning, image navigation, noise filtering, and solar intrusion assessment, resulting in a GLM calibration parameter file. The PLPT includes four main activities, the Reference Data Comparisons (RDC), Algorithm Testing (AT), Instrument Navigation and Registration Testing (INRT), and Long Term Baseline Testing (LTBT). Field campaigns are also designed to contribute valuable insights into the GLM performance capabilities. The PLPT tests each contribute to the beta, provisional, and fully validated GLM data

Fluidized Bed Polymer Particle ALD Process for Producing HDPE/Alumina Nanocomposites

Micron-sized High Density Polyethylene (HDPE) particles were coated with ultrathin alumina (Al2O3) films in a Fluidized Bed Reactor (FBR) by Atomic Layer Deposition (ALD) at 77 ºC. Al2O3 films on the HDPE particles were confirmed by different methods. These particles were extruded conventionally with the ceramic shells mixing intimately in the polymer matrix. The successful dispersion of the Al2O3 shells in the polymer matrix following extrusion was confirmed using cross sectional Transmission Electron Microscopy (TEM)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive, Early Breast Cancer

Background EarlyR gene signature in estrogen receptor–positive (ER+) breast cancer is computed from the expression values of ESPL1, SPAG5, MKI67, PLK1, and PGR. EarlyR has been validated in multiple cohorts profiled using microarrays. This study sought to verify the prognostic features of EarlyR in a case-cohort sample from BIG 1–98, a randomized clinical trial of ER+ postmenopausal breast cancer patients treated with adjuvant endocrine therapy (letrozole or tamoxifen). Methods Expression of EarlyR gene signature was estimated by Illumina cDNA-mediated Annealing, Selection, and Ligation assay of RNA from formalin-fixed, paraffin-embedded primary breast cancer tissues in a case-cohort subset of ER+ women (N = 1174; 216 cases of recurrence within 8 years) from BIG 1–98. EarlyR score and prespecified risk strata (≤25 = low, 26–75 = intermediate, >75 = high) were “blindly” computed. Analysis endpoints included distant recurrence–free interval and breast cancer–free interval at 8 years after randomization. Hazard ratios (HRs) and test statistics were estimated with weighted analysis methods. Results The distribution of the EarlyR risk groups was 67% low, 19% intermediate, and 14% high risk in this ER+ cohort. EarlyR was prognostic for distant recurrence–free interval; EarlyR high-risk patients had statistically increased risk of distant recurrence within 8 years (HR = 1.73, 95% confidence interval = 1.14 to 2.64) compared with EarlyR low-risk patients. EarlyR was also prognostic of breast cancer–free interval (HR = 1.74, 95% confidence interval = 1.21 to 2.62). Conclusions This study confirmed the prognostic significance of EarlyR using RNA from formalin-fixed, paraffin-embedded tissues from a case-cohort sample of BIG 1–98. EarlyR identifies a set of high-risk patients with relatively poor prognosis who may be considered for additional treatment. Further studies will focus on analyzing the predictive value of EarlyR signature

The GOES-R Geostationary Lightning Mapper (GLM) and the Global Observing System for Total Lightning

for the existing GOES system currently operating over the Western Hemisphere. New and improved instrument technology will support expanded detection of environmental phenomena, resulting in more timely and accurate forecasts and warnings. Advancements over current GOES include a new capability for total lightning detection (cloud and cloud-to-ground flashes) from the Geostationary Lightning Mapper (GLM), and improved temporal, spatial, and spectral resolution for the next generation Advanced Baseline Imager (ABI). The GLM will map total lightning continuously day and night with near-uniform spatial resolution of 8 km with a product latency of less than 20 sec over the Americas and adjacent oceanic regions. This will aid in forecasting severe storms and tornado activity, and convective weather impacts on aviation safety and efficiency among a number of potential applications. The GLM will help address the National Weather Service requirement for total lightning observations globally to support warning decision-making and forecast services. Science and application development along with pre-operational product demonstrations and evaluations at NWS national centers, forecast offices, and NOAA testbeds will prepare the forecasters to use GLM as soon as possible after the planned launch and check-out of GOES-R in 2016. New applications will use GLM alone, in combination with the ABI, or integrated (fused) with other available tools (weather radar and ground strike networks, nowcasting systems, mesoscale analysis, and numerical weather prediction models) in the hands of the forecaster responsible for issuing more timely and accurate forecasts and warnings

New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo guidelines

Background: The Tokyo Guidelines for the management of acute cholangitis and cholecystitis were published in 2007 (TG07) and have been widely cited in the world literature. Because of new information that has been published since 2007, we organized the Tokyo Guidelines Revision Committee to conduct a multicenter analysis to develop the updated Tokyo Guidelines (TG13). Methods/materials : We retrospectively analyzed 1,432 biliary disease cases where acute cholangitis was suspected. The cases were collected from multiple tertiary care centers in Japan. The 'gold standard' for acute cholangitis in this study was that one of the three following conditions was present: (1) purulent bile was observed; (2) clinical remission following bile duct drainage; or (3) remission was achieved by antibacterial therapy alone, in patients in whom the only site of infection was the biliary tree. Comparisons were made for the validity of each diagnostic criterion among TG13, TG07 and Charcot's triad. Results: The major changes in diagnostic criteria of TG07 were re-arrangement of the diagnostic items and exclusion of abdominal pain from the diagnostic list. The sensitivity improved from 82.8 % (TG07) to 91.8 % (TG13). While the specificity was similar to TG07, the false positive rate in cases of acute cholecystitis was reduced from 15.5 to 5.9 %. The sensitivity of Charcot's triad was only 26.4 % but the specificity was 95.6 %. However, the false positive rate in cases of acute cholecystitis was 11.9 % and not negligible. As for severity grading, Grade II (moderate) acute cholangitis is defined as being associated with any two of the significant prognostic factors which were derived from evidence presented recently in the literature. The factors chosen allow severity assessment to be performed soon after diagnosis of acute cholangitis. Conclusion: TG13 present a new standard for the diagnosis, severity grading, and management of acute cholangitis. © 2012 The Author(s).link_to_subscribed_fulltex

New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo guidelines

Background: The Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) were published in 2007 as the world's first guidelines for acute cholangitis and cholecystitis. The diagnostic criteria and severity assessment of acute cholecystitis have since been widely used all over the world. A validation study of TG07 has shown that the diagnostic criteria for acute cholecystitis are highly reliable but that the definition of definite diagnosis is ambiguous. In addition, considerable new evidence referring to acute cholecystitis as well as evaluations of TG07 have been published. Consequently, we organized the Tokyo Guidelines Revision Committee to evaluate TG07, recognize new evidence, and conduct a multi-center analysis to revise the guidelines (TG13). Methods and materials: We retrospectively analyzed 451 patients with acute cholecystitis from multiple tertiary care centers in Japan. All 451 patients were first evaluated using the criteria in TG07. The "gold standard" for acute cholecystitis in this study was a diagnosis by pathology. The validity of TG07 diagnostic criteria was investigated by comparing clinical with pathological diagnosis. Results: Of 451 patients evaluated, a total of 227 patients were given a diagnosis of acute cholecystitis by pathological examination (prevalence 50.3 %). TG07 criteria provided a definite diagnosis of acute cholecystitis in 224 patients. The sensitivity of TG07 diagnostic criteria for acute cholecystitis was 92.1 %, and the specificity was 93.3 %. Based on the preliminary results, new diagnostic criteria for acute cholecystitis were proposed. Using the new criteria, the sensitivity of definite diagnosis was 91.2 %, and the specificity was 96.9 %. The accuracy rate was improved from 92.7 to 94.0 %. In regard to severity grading among 227 patients, 111 patients were classified as Mild (Grade I), 104 as Moderate (Grade II), and 12 as Severe (Grade III). Conclusion: The proposed new diagnostic criteria achieved better performance than the diagnostic criteria in TG07. Therefore, the proposed criteria have been adopted as new diagnostic criteria for acute cholecystitis and are referred to as the 2013 Tokyo Guidelines (TG13). Regarding severity assessment, no new evidence was found to suggest that the criteria in TG07 needed major adjustment. As a result, TG07 severity assessment criteria have been adopted in TG13 with minor changes. © 2012 The Author(s).link_to_subscribed_fulltex

The Transformation of the Woman Suffrage Movement: The Case of Illinois, 1850-1920

https://cornerstone.lib.mnsu.edu/university-archives-msu-authors/1133/thumbnail.jp

Women\u27s Movements in the United States: Woman Suffrage, Equal Rights, and Beyond

Steven Buecheler has written a comparative sociological analysis of the woman suffrage movement (1840s-1920) and the contemporary women’s movement (1960s to the present). His identification of similarities and differences between these movements reveals persistent feminist issues over time as well as the distinctive concerns of each movement in the sociohistorical context. Buecheler compares these two movements in terms of their origins, organizations, ideologies, class and racial diversities, countermovement’s, and outcomes. He uses resource mobilization theory. Buecheler explains why women’s movements arise, the forms of organization they adopt, the diversity of ideologies they espouse, and the class and racial composition of women’s movements. He also helps us to understand the roots of countermovements, as well as the mixture of successes and failures that has characterized both past and present women’s movements. While recognizing both the setbacks and the victories of the contemporary movement, Buecheler identifies grounds for relative optimism about the lasting consequences of this ongoing mobilization. Buechler also explores the complex relationship between social change and social movements. Rapid change both enables and constricts the potential for collective action, which in turn reshapes social structure, By studying long-lived moments in a comparative framework, Buechler sheds light on the broader dialectical relation between agency and structure that is embodied in movement efforts at social change.https://cornerstone.lib.mnsu.edu/university-archives-msu-authors/1134/thumbnail.jp

Wnt5a Signaling in Cancer

Wnt5a is involved in activating several non-canonical WNT signaling pathways, through binding to different members of the Frizzled- and Ror-family receptors. Wnt5a signaling is critical for regulating normal developmental processes, including proliferation, differentiation, migration, adhesion and polarity. However, the aberrant activation or inhibition of Wnt5a signaling is emerging as an important event in cancer progression, exerting both oncogenic and tumor suppressive effects. Recent studies show the involvement of Wnt5a in regulating cancer cell invasion, metastasis, metabolism and inflammation. In this article, we review findings regarding the molecular mechanisms and roles of Wnt5a signaling in various cancer types, and highlight Wnt5a in ovarian cancer